Oculoplastics News

A sutureless wound closure technique led to less scarring and better cosmesis than subcuticular technique in external dacryocystorhinostomy procedures.

Lesion reduction was sustained and visual function improved in eyes treated with fractionated stereotactic radiotherapy for cavernous venous malformation of the orbital apex.

Oculoplastic surgeons have been frustrated watching their patients with thyroid eye disease in active phase and not having an FDA-approved drug to help, Roger A. Dailey, MD, FACS, told Healio.com/OSN.

A 30-year-old woman presented urgently to the New England Eye Center with several months of progressive vision loss, swelling and intermittent pain in the right eye.

Horizon Therapeutics has submitted a biologics license application to the FDA for its investigational thyroid eye disease treatment candidate teprotumumab, according to a press release.

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Daniel C. Garibaldi, MD, FACS, shares his procedure for repairing eyelid laxity in preparation for ocular surgery.

A 56-year-old male property manager with no ocular history was referred to the New England Eye Center by an outside ophthalmologist for evaluation of eyelid asymmetry. For 5 months, the patient had noticed that his left upper eyelid appeared lower than his right upper eyelid. He felt the position of his eyelids changed through the day and seemed more equal after rest. He had no diplopia or difficulty moving his eyes. He did not report any palpitations, heat/cold intolerance or weight fluctuations, although he did endorse lower energy over the last few years. A few years before presentation, he was involved in a motor vehicle accident and sustained head injuries but reportedly had no eye trauma.

A 34-year-old woman was transferred to the University of New Mexico emergency department with a 3-day history of progressive left eye swelling. She complained of mild blurry vision, diplopia, discomfort with eye movements and difficulty opening the left eye. She also noted foul-smelling left-sided nasal discharge, subjective fevers and nausea for the past 3 days. She reported having a history of left-sided epistaxis requiring nasal cautery about 2 or 3 years before presentation. She also had a 1-year history of increased tearing in the left eye. She had no other significant medical or surgical history. Her family history was noncontributory. She used over-the-counter nasal spray. She denied tobacco and recreational drug use and reported occasional alcohol use.

An experimental human monoclonal antibody dramatically reduced the most debilitating symptoms of Graves’ orbitopathy, including proptosis and double vision, giving new hope to patients that a treatment for thyroid eye disease may finally be within reach, according to a speaker at the AACE Annual Scientific and Clinical Congress.

Results from the phase 3 OPTIC study showed more patients treated with teprotumumab had a meaningful improvement in proptosis compared with those who received placebo.